Clinical trials
Phase 3 Metabolic Diseases trials in Australia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 1 |
| 2010 | 1 |
| 2014 | 2 |
| 2018 | 1 |
| 2020 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2024 | 3 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 6 |
| Active, not recruiting | 2 |
| Recruiting | 2 |
| Unknown status | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eli Lilly and Company | 3 |
| 89bio, Inc. | 2 |
| Amgen | 1 |
| AstraZeneca | 1 |
| Calcilytix Therapeutics, Inc., a BridgeBio company | 1 |
| Olive Lifesciences Pvt Ltd | 1 |
| Takeda | 1 |
| iECURE, Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Metabolic Diseases | 11 |
| Diabetes Mellitus, Type 2 | 5 |
| Glucose Metabolism Disorders | 5 |
| Diabetes Mellitus | 4 |
| Endocrine System Diseases | 4 |
| Liver Diseases | 3 |
| Digestive System Diseases | 2 |
| Fatty Liver | 2 |
| Fibrosis | 2 |
| Non-alcoholic Fatty Liver Disease | 2 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.